![]() |
Malignant Lymphoma |
Free Subscription
2 Am J Clin Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Malignant Lymphoma is free of charge.
IRTA1 expression in extranodal marginal zone (MALT) lymphoma is variable across
anatomic sites.
Am J Clin Pathol. 2025 Jun 30:aqaf056. doi: 10.1093.
PubMed
Abstract available
Concurrent or subsequent lymphomatous effusion in large B-cell lymphoma portends
a dismal prognosis: A multi-institutional study.
Am J Clin Pathol. 2025 Jun 29:aqaf057. doi: 10.1093.
PubMed
Abstract available
Association Between Moraxella catarrhalis and Nodular Lymphocyte-Predominant
Hodgkin Lymphoma.
Am J Hematol. 2025 Jul 4. doi: 10.1002/ajh.27762.
PubMed
Abstract available
Genomics of T-Cell Lymphomas With CD30/CD15 Co-Expression: Comparison With
Anaplastic Large-Cell Lymphoma, ALK-Negative.
Am J Surg Pathol. 2025 Jul 3. doi: 10.1097/PAS.0000000000002447.
PubMed
Abstract available
Early assessment of therapeutic efficacy in lymphoma patients via a blood-based
multi-omics response monitoring test.
BMC Cancer. 2025;25:1078.
PubMed
Abstract available
Clinically probable paraneoplastic vasculitic peripheral neuropathy in primary
central nervous system lymphoma: a case report.
BMC Neurol. 2025;25:252.
PubMed
Abstract available
Correction: Non-cryopreserved autologous peripheral blood stem cell
transplantation for multiple myeloma and lymphoma in countries with limited
resources: practice considerations from the Worldwide Network for Blood and
Marrow Transplantation.
Bone Marrow Transplant. 2025 Jun 30. doi: 10.1038/s41409-025-02664.
PubMed
Therapeutic advances and gradual improvement in overall survival in mantle cell
lymphoma over four decades.
Br J Haematol. 2025 Jul 2. doi: 10.1111/bjh.20239.
PubMed
Vitrectomy as a rapid diagnostic tool for lymphoma: Cytology and flow cytometry
approach.
Br J Haematol. 2025 Jul 1. doi: 10.1111/bjh.20250.
PubMed
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from
a multicentre experience.
Br J Haematol. 2025 Jul 1. doi: 10.1111/bjh.20234.
PubMed
Abstract available
Acute kidney injury after chimeric antigen receptor T-cell therapy is associated
with inferior survival in patients with relapsed/refractory large B-cell
lymphoma.
Br J Haematol. 2025 Jun 30. doi: 10.1111/bjh.20240.
PubMed
Abstract available
Construction of Lymphoma Organoids and Applications in Tumor Microenvironment
Research.
Eur J Haematol. 2025 Jun 30. doi: 10.1111/ejh.14448.
PubMed
Abstract available
Safety and efficacyof the combination of copanlisib and nivolumab in patients
with Richter's transformation or transformed non-Hodgkin lymphoma: results from a
phase I trial.
Haematologica. 2025 Jul 3. doi: 10.3324/haematol.2024.286945.
PubMed
Abstract available
Minimal residual disease status predicts outcomes in patients with follicular
lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial.
Haematologica. 2025 Jul 3. doi: 10.3324/haematol.2025.288057.
PubMed
Abstract available
BTKi +humanized anti-CD20 for advanced follicular lymphoma: ready for an
ALTERNATIVE?
Haematologica. 2025 Jul 3. doi: 10.3324/haematol.2025.288196.
PubMed
Abstract available
Comparison of Contemporary Radiotherapy Approaches in Combined Modality Treatment
on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331.
Int J Radiat Oncol Biol Phys. 2025 Jun 28:S0360-3016(25)04518.
PubMed
Abstract available
Clonal hematopoiesis and subsequent venous thromboembolism among survivors of
autologous transplantation for lymphoma.
J Natl Cancer Inst. 2025 Jul 2:djaf164. doi: 10.1093.
PubMed
Abstract available
Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: drug
profile and expert opinion on the prevention and management of adverse events.
Leuk Lymphoma. 2025 Jun 30:1-13. doi: 10.1080/10428194.2025.2520440.
PubMed
Abstract available
T-cell neoplasias and secondary malignancies after CAR-T cell therapy: current
knowledge, risk factors, and implications from CAR-T engineering strategies.
Leuk Lymphoma. 2025;66:1189-1197.
PubMed
Abstract available
Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with
higher-intensity therapy in the rituximab era: insights from a retrospective
analysis.
Leuk Lymphoma. 2025;66:1276-1283.
PubMed
Abstract available
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid
cells.
Leukemia. 2025;39:1756-1768.
PubMed
Abstract available
Advances in lymphoma biomarkers research based on proteomics technology (Review).
Oncol Rep. 2025;54:108.
PubMed
Abstract available
Extranodal NK/T-Cell Lymphoma Misdiagnosed as Pulmonary Infection.
Oncology (Williston Park). 2025;null:198-203.
PubMed
Abstract available
Thank you for your interest in scientific medicine.